Arsenic Trioxide
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients
1997 • 1,431 citations
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
1998 • 761 citations
Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma
2000 • 547 citations
Malignant Cells Can Be Sensitized to Undergo Growth Inhibition and Apoptosis by Arsenic Trioxide Through Modulation of the Glutathione Redox System
1999 • 538 citations
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
2001 • 420 citations
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis
2000 • 271 citations
The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
1998 • 159 citations
Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As2O3) on myeloma cells
2001 • 68 citations
The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
2000 • 61 citations
Arsenicals in hematologic cancers.
2000 • 57 citations
Cited By (0)
No citing papers found in database